Ad is loading...
RSPYX
Price
$34.06
Change
-$0.15 (-0.44%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

RSPYX vs VISVX

Header iconRSPYX vs VISVX Comparison
Open Charts RSPYX vs VISVXBanner chart's image
Victory RS Partners Y
Price$34.06
Change-$0.15 (-0.44%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
RSPYX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RSPYX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSPYX is a StrongBuy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. RSPYX (572M). VISVX pays higher dividends than RSPYX: VISVX (1.90) vs RSPYX (0.93). RSPYX was incepted earlier than VISVX: RSPYX (18 years) vs VISVX (27 years). RSPYX is a more actively managed with annual turnover of: 72.00 vs. VISVX (16.00). VISVX has a lower initial minimum investment than RSPYX: VISVX (3000) vs RSPYX (1000000). VISVX annual gain was more profitable for investors over the last year : 28.71 vs. RSPYX (24.92). VISVX return over 5 years is better than : 57.32 vs. RSPYX (28.71).
RSPYXVISVXRSPYX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years27 years-
Gain YTD19.93015.433129%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets572M57.6B1%
Annual Yield % from dividends0.931.9049%
Returns for 1 year24.9228.7187%
Returns for 3 years-1.4813.23-11%
Returns for 5 years28.7157.3250%
Returns for 10 years-10.82108.21-10%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics